Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04266275 · ClinicalTrials.gov registry record · Phase 2
Topical Curcumin for HPV Related Cervical Disease
A Phase 2 study, sponsored by Lisa Flowers.
- Not yet
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT04266275 is a Phase 2 study that has not yet begun recruiting, run by Lisa Flowers. The registered enrollment target is 200 participants.
The verdict
NCT04266275, a Phase 2 study, has not yet begun recruiting, sponsored by Lisa Flowers.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to see if curcumin can suppress HPV infection in women with low-grade squamous intraepithelial lesions (LSIL) disease or treated high-grade squamous intraepithelial lesions (HSIL) disease. This study plans to explore the effect of curcumin as a potential medical treatment in HIV-uninfected and infected women with mild precancerous lesions of the cervix or recently treated high-grade precancerous lesions at risk for persistent HPV infection. About 200 women with low-grade precancerous lesions of the cervix or recently treated high-grade precancerous lesions will be enrolled to either insert 2000 mg of curcumin capsules in their vagina once a week or placebo after undergoing colposcopy or loop electrosurgical excision procedure (LEEP). They will have a repeat visit in 6 months where they will undergo a Pap smear and HPV test to determine if there are higher rates of HPV clearance after curcumin administration. If HPV is present or the Pap smear is abnormal, patients will then undergo colposcopic examination to evaluate cervical histology.
Interventions
- DRUG Placebo
- DRUG Curcumin C3 Complex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2027-04 |
| Est. Completion | 2028-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04266275
The ClinicalTrials.gov registry entry for NCT04266275 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lisa Flowers, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04266275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04266275 about?
NCT04266275 is a clinical study titled "Topical Curcumin for HPV Related Cervical Disease". The purpose of this study is to see if curcumin can suppress HPV infection in women with low-grade squamous intraepithelial lesions (LSIL) disease or treated high-grade squamous intraepithelial lesions (HSIL) disease. This study plans to explore the effect of curcumin as a potential medical treatmen...
What is the current status of trial NCT04266275?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2027-04. Estimated completion is 2028-10.
What interventions are being tested in trial NCT04266275?
The interventions under investigation include: Placebo (DRUG), Curcumin C3 Complex (DRUG).
Who is sponsoring clinical trial NCT04266275?
This trial is sponsored by Lisa Flowers, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.